Radiopharm Theranostics (RADX) Assets (2024 - 2025)
Radiopharm Theranostics (RADX) has disclosed Assets for 2 consecutive years, with $86.5 million as the latest value for Q2 2025.
- On a quarterly basis, Assets rose 20.05% to $86.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $86.5 million, a 20.05% increase, with the full-year FY2025 number at $86.5 million, up 20.05% from a year prior.
- Assets was $86.5 million for Q2 2025 at Radiopharm Theranostics, up from $72.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $86.5 million in Q2 2025 to a low of $72.0 million in Q2 2024.